StudyID: Okishige 2000, atrial fibrillation, persistent
DISEASE INTERVENTION COMPARISON RESULTS
Am Heart J. 2000 Sep;140(3):437-44 Randomized Controlled Trial
IN StudyID: Okishige 2000, atrial fibrillation, persistent The Use of
pilsicainide
As Treatment, Chronic
Is better Than
placebo
To AF recurrence, mortality, adverse effects - at 12 and 24 months